MRNS - Marinus Pharmaceuticals sees FY23 U.S. ZTALMY revenue $19.5M-$19.7M
2024-01-04 12:45:20 ET
More on Marinus Pharmaceuticals
- Marinus Pharmaceuticals: A Capital Raise Is On The Horizon
- Marinus Pharmaceuticals, Inc. (MRNS) Q3 2023 Earnings Call Transcript
- Marinus slips despite guidance raise amid delay for key readout
- Marinus Pharmaceuticals Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Marinus Pharmaceuticals
For further details see:
Marinus Pharmaceuticals sees FY23 U.S. ZTALMY revenue $19.5M-$19.7M